Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant

• US 8,927,203 B2
• Filed: 10/21/2011
• Issued: 01/06/2015
• Est. Priority Date: 01/12/2005
• Status: Expired due to Fees

• Current Assignee: Biovec Transfusion LLC
• Original Assignee: Biovec Transfusion LLC
• Inventors: Sehgal, Lakshman R.
• Primary Examiner(s): SAUCIER, SANDRA E
• Application Number:
  US13/278,553
• Publication Number:
  US 20120058558A1
• Time in Patent Office: 1,173 Days
• US Class Current: 435/2
• CPC Class Codes: A01N 1/02 Preservation of living parts
• CPC Class Codes: A01N 1/0215 Disinfecting agents, e.g. antimicrobials for preserving living parts
• CPC Class Codes: A01N 1/0226 Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients

Abstract

The present invention relates to compositions and methods for storing platelets to preserve the function and freshness of the platelets. More particularly, the present invention relates to the use of a preservative composition having an antiplatelet agent, an anticoagulant, and an oxygen carrier, for maintaining the freshness of platelets. Additionally, the composition may also contain an ultra-short acting broad spectrum anti-microbial agents. The preservative composition may be used to store platelets in a liquid state, a frozen state, or a freeze-dried state.

Claims

1. A platelet preservation package, comprising:

a platelet preservation composition comprising;

a short-to-ultrashort acting antiplatelet agent, wherein said antiplatelet agent is a GPIIb/IIIa inhibitor;

a short-to-ultrashort acting anticoagulant, wherein said anticoagulant is a compound that reversibly inhibits factor Xa, or factor IIa, or both; and

a bag for storing the platelet preservation composition,

wherein said antiplatelet agent and said anticoagulant are stored in said bag and wherein said composition is capable of extending the shelf-life of platelets when mixed with said platelets in said bag.

2. The platelet preservation package of claim 1, wherein said antiplatelet agent is capable of reversibly blocking platelet activation and/or aggregation by blocking sites on the platelet surface.

3. The platelet preservation package of claim 1, wherein said antiplatelet agent is selected from the group consisting of eptifibatide, orbofiban, xemilofiban, lamifiban, tirofiban, and mixtures thereof.

4. The platelet preservation package of claim 1, wherein said antiplatelet agent is selected from the group consisting of linear and cyclic RGD-containing peptides.

5. The platelet preservation package of claim 4, wherein said linear and cyclic RGD-containing peptides are conjugated to a nitric oxide donor.

6. The platelet preservation package of claim 1, wherein said antiplatelet agent is a pharmaceutically acceptable antiplatelet agent and has a circulating half-life of inhibition of about less than 4 hours.

7. The platelet preservation package of claim 1, wherein said antiplatelet agent comprises about 0.001 mg to about 5 mg of a GPIIb/IIIa inhibitor.

8. The platelet preservation package of claim 1, wherein said anticoagulant is a short-to-ultrashort acting Xa inhibitor with a circulating half-life of less than 4 hours.

9. The platelet preservation package of claim 1, wherein said anticoagulant is a short-to-ultrashort acting IIa inhibitor, and wherein said short-to-ultrashort acting IIa inhibitor is selected from the group consisting of hirudin, hirulog, melgatran, and combinations thereof.

10. The platelet preservation package of claim 1, wherein said anticoagulant is a pharmaceutically acceptable anticoagulant and is a combination of at least one short-to-ultrashort acting IIa inhibitor, and at least one short-to-ultrashort acting Xa inhibitor.

11. The platelet preservation package of claim 1, wherein the preserved platelet composition further comprises a short-to-ultrashort acting broad spectrum anti-microbial agent selected from the group consisting of:

natural penicillins, semisynthetic penicillins, monobactam, cephalosporin, carbapenems, vancomycin, isoniazid, ethambutol, aminoglycoside, tetracycline, chloramphenicol, macrolide, rifamycin, quinolone, fluoroquinolone, sulfonamide, polyene antibiotic, imidazole, triazole, griseofulvin and combinations thereof.

12. A platelet preservation package, comprising:

a platelet preservation composition comprising;

a short-to-ultrashort acting antiplatelet agent, wherein said antiplatelet agent is a GPIIb/IIIa inhibitor;

a short-to-ultrashort acting anticoagulant, wherein said anticoagulant is a compound that reversibly inhibits factor Xa; and

a blood collection bag,

wherein said antiplatelet agent and said anticoagulant are stored in said blood collection bag and wherein said composition is capable of extending the shelf-life of platelets when mixed with said platelets in said blood collection bag.

13. A platelet preservation package, comprising:

a platelet preservation composition comprising;

a short-to-ultrashort acting antiplatelet agent, wherein said antiplatelet agent is a GPIIb/IIIa inhibitor;

a short-to-ultrashort acting anticoagulant, wherein said anticoagulant is a compound that reversibly inhibits factor IIa; and

a blood collection bag,

wherein said antiplatelet agent and said anticoagulant are stored in said blood collection bag and wherein said composition is capable of extending the shelf-life of platelets when mixed with said platelets in said blood collection bag.